Healthcare Stocks Scatter Chart

219 companies Sector P/E vs Revenue Growth (1y) (TTM)
Universe
Plot any two of 343 metrics The preset pairs are free. Subscribers can put any metric on either axis.
Highlight

P/E vs Revenue Growth (1y) (TTM)

Company Outlier, pinned to the edge Highlighted Trend

Each dot is one of the 219 Healthcare stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 10.1% and the median P/E 23.02. Pinned to the edge: 16 outliers on X and 9 on Y.

Rank correlation 0.07 Trend R² 0.06 X middle half 4.1% to 25.3% Y middle half 11.30 to 40.09
58High Revenue Growth (1y) (TTM), high P/E
52Low Revenue Growth (1y) (TTM), high P/E
57Low Revenue Growth (1y) (TTM), low P/E
52High Revenue Growth (1y) (TTM), low P/E

Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.

Companies

219 plotted
# Industry
1 LLYEli Lilly 45.5% 46.74 $1.36T Pharmaceuticals
2 JNJJohnson & Johnson 7.8% 42.83 $688.76B Pharmaceuticals
3 ABBVAbbVie 10.7% 50.48 $521.69B Pharmaceuticals
4 UNHUnitedhealth 3.3% 23.02 $365.22B Managed Care
5 MRKMerck 4.9% 148.68OUT $364.31B Pharmaceuticals
6 AZNAstrazeneca 7.8% 25.92 $285.96B Pharmaceuticals
7 TMOThermo Fisher Scientific 8.3% 36.63 $259.44B Life Sciences Tools
8 AMGNAmgen 8.2% 26.83 $251.88B Biotechnology
9 ABTAbbott Laboratories 10.0% 40.05 $187.98B Medical Devices
10 PFEPfizer 1.3% 40.85 $164.73B Pharmaceuticals
11 DHRDanaher 5.5% 37.87 $163.91B Life Sciences Tools
12 ISRGIntuitive Surgical 20.5% 52.35 $153.75B Medical Devices
13 VRTXVertex Pharmaceuticals 10.5% 34.34 $136.55B Biotechnology
14 MDTMedtronic 12.8% 15.04 $131.67B Medical Devices
15 BMYBristol Myers Squibb 4.2% 14.02 $129.66B Pharmaceuticals
16 MCKMckesson 8.2% 27.29 $127.33B Drug Distribution
17 SYKStryker 7.9% 32.65 $117.84B Medical Devices
18 CVSCvs Health 6.7% 10.38 $114.34B Managed Care
19 GSKGsk 82.9% 8.11 $108.86B Pharmaceuticals
20 HCAHCA Healthcare 5.8% 15.81 $105.29B Hospitals
21 REGNRegeneron Pharmaceuticals 18.6% 20.17 $97.17B Biotechnology
22 ELVElevance Health 3.6% 18.11 $92.86B Managed Care
23 CICigna 6.8% 13.03 $78.25B Managed Care
24 CORCencora 5.0% 22.64 $68.51B Drug Distribution
25 CAHCardinal Health 10.0% 35.87 $64.97B Drug Distribution
26 BSXBoston Scientific 8.9% 18.34 $64.27B Medical Devices
27 EWEdwards Lifesciences 13.4% 60.87 $61.69B Medical Devices
28 ARGXArgenx Se 61.5% 31.35 $59.41B Biotechnology
29 SNYSanofi -19.6% 6.24 $58.98B Pharmaceuticals
30 IDXXIdexx Laboratories 11.9% 46.96 $55.49B Animal Health
31 HUMHumana 22.0% 43.42 $54.10B Managed Care
32 TEVATeva Pharmaceutical Industries 2.7% 102.64 $51.97B Generic Drugs
33 AAgilent Technologies 8.6% 34.06 $49.04B Life Sciences Tools
34 ONCBeOne Medicines 32.9% 51.73 $47.53B Pharmaceuticals
35 IQVIqvia Holdings 8.8% 31.30 $43.67B Contract Research
36 GEHCGE HealthCare Technologies 6.9% 17.42 $37.54B Diagnostic Equipment
37 BIIBBiogen 2.3% 107.78 $37.46B Biotechnology
38 ALCAlcon 8.0% 54.90 $36.13B Medical Devices
39 ZTSZoetis 0.9% 13.76 $34.16B Animal Health
40 RMDResmed 9.0% 21.50 $33.69B Medical Devices
41 ILMNIllumina 5.8% 34.93 $31.30B Life Sciences Tools
42 DXCMDexcom 13.0% 31.51 $31.08B Medical Devices
43 LHLabcorp Holdings 6.0% 29.94 $30.09B Diagnostic Labs
44 PHGKoninklijke Philips 53.4% 15.11 $29.22B Diagnostic Equipment
45 WSTWest Pharmaceutical Services 12.6% 45.92 $29.09B Medical Supplies
46 DGXQuest Diagnostics 9.1% 25.31 $28.58B Diagnostic Labs
47 STESteris 8.1% 31.11 $25.67B Medical Devices
48 UTHRUnited Therapeutics 1.9% 20.51 $25.06B Pharmaceuticals
49 ALNYAlnylam Pharmaceuticals 60.8% 8.34 $22.09B Biotechnology
50 ZBHZimmer Biomet Holdings 7.0% 25.63 $19.53B Medical Devices
51 MEDPMedpace Holdings 20.4% 35.28 $18.29B Contract Research
52 RVTYRevvity 4.6% 68.10 $17.25B Life Sciences Tools
53 ASNDAscendis Pharma A 93.8%OUT 16.31 $17.07B Biotechnology
54 NBIXNeurocrine Biosciences 38.0% 24.21 $16.96B Pharmaceuticals
55 EXELExelixis 9.1% 19.24 $16.88B Pharmaceuticals
56 CRLCharles River Laboratories International -1.2% 402.10OUT $16.18B Contract Research
57 SOLVSolventum -2.8% 97.50 $15.13B Medical Devices
58 KNSAKiniksa Pharmaceuticals International 58.2% 68.75 $15.13B Biotechnology
59 ICLRIcon 1.8% 34.02 $14.90B Contract Research
60 BTSGBrightSpring Health Services 26.0% 35.93 $14.16B Home Health and Senior Care
61 EHCEncompass Health 9.4% 21.50 $13.83B Hospitals
62 PENPenumbra 17.0% 80.51 $12.65B Medical Devices
63 RDYDr Reddys Laboratories -10.5% 33.78 $12.31B Generic Drugs
64 COOCooper Companies 4.7% 21.20 $11.91B Medical Devices
65 ALGNAlign Technology 4.4% 24.29 $11.90B Dental
66 TECHBio-Techne 0.9% 66.38 $11.43B Life Sciences Tools
67 HALOHalozyme Therapeutics 45.0% 23.51 $11.42B Biotechnology
68 DVADavita 6.4% 12.11 $11.06B Healthcare Services
69 ENSGEnsign 17.5% 27.30 $10.99B Home Health and Senior Care
70 QGENQiagen 2.2% 28.16 $10.82B Life Sciences Tools
71 PODDInsulet 26.5% 24.66 $10.58B Medical Devices
72 BIOBio-Rad Laboratories 1.4% 9.59 $9.85B Life Sciences Tools
73 UHSUniversal Health Services 8.0% 7.82 $9.80B Hospitals
74 TGTXTg Therapeutics 68.8% 85.63 $9.75B Biotechnology
75 GMEDGlobus Medical 13.4% 17.35 $9.56B Medical Devices
76 HSICHenry Schein 6.2% 22.79 $9.53B Drug Distribution
77 HNGEHinge Health 49.9% 56.01 $9.37B Telehealth
78 KRYSKrystal Biotech 26.0% 40.14 $9.04B Gene and Cell Therapy
79 OSCROscar Health 54.8% 11.23 $8.56B Managed Care
80 PTGXProtagonist Therapeutics 163.7%OUT 25.39 $8.54B Biotechnology
81 CORTCorcept Therapeutics 30.0% 48.81 $7.98B Pharmaceuticals
82 PACSPacs 11.0% 27.59 $7.67B Home Health and Senior Care
83 AMRXAmneal Pharmaceuticals 8.9% 53.85 $7.45B Generic Drugs
84 CHEChemed 5.2% 25.36 $7.14B Home Health and Senior Care
85 LNTHLantheus Holdings 2.4% 24.58 $6.64B Diagnostic Equipment
86 CAICaris Life Sciences 61.5% 68.09 $6.61B Diagnostic Labs
87 LGNDLigand Pharmaceuticals 1.0% 119.78 $6.18B Biotechnology
88 FMSFresenius Medical Care AG -49.1% 6.71 $6.16B Healthcare Services
89 TFXTeleflex 20.9% 21.11 $6.15B Medical Devices
90 HAEHaemonetics 4.1% 53.80 $5.59B Medical Devices
91 CONConcentra Group Holdings Parent 11.8% 24.46 $5.38B Healthcare Services
92 MMSIMerit Medical Systems 9.1% 32.36 $5.19B Medical Devices
93 LIVNLivaNova 11.7% 25.66 $5.03B Medical Devices
94 EWTXEdgewise Therapeutics 36.6% 4.95 $5.03B Pharmaceuticals
95 BLLNBillionToOne 71.9% 108.18 $5.01B Diagnostic Labs
96 STVNStevanato Group S.p.A 12.0% 26.46 $4.78B Medical Supplies
97 SHCSotera Health 6.9% 27.38 $4.74B Diagnostic Labs
98 OPCHOption Care Health 4.0% 22.03 $4.74B Home Health and Senior Care
99 ICUIIcu Medical -5.9% 74.31 $4.48B Medical Devices
100 CRVLCorvel 8.3% 35.64 $4.32B Managed Care

Frequently Asked Questions

Which Healthcare stocks look cheap relative to their growth?

Among Healthcare stocks, the largest companies growing revenue faster than the median (10.1%) while trading below the median P/E (23.02) are Medtronic (MDT), Gsk (GSK), Regeneron Pharmaceuticals (REGN), Koninklijke Philips (PHG) and Alnylam Pharmaceuticals (ALNY). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.

Which Healthcare stocks are expensive for their growth?

The largest companies with a P/E above the median and revenue growth below it are Johnson & Johnson (JNJ), Unitedhealth (UNH), Merck (MRK), Astrazeneca (AZN) and Thermo Fisher Scientific (TMO).

What is the median P/E of Healthcare stocks?

The median P/E across the 219 Healthcare stocks plotted is 23.02, with the middle half between 11.30 and 40.09.

What is the median Revenue Growth (1y) (TTM) of Healthcare stocks?

The median is 10.1%, with the middle half between 4.1% and 25.3%.

Is there a relationship between Revenue Growth (1y) (TTM) and P/E for Healthcare stocks?

The rank correlation (Spearman) is 0.07, a no meaningful positive relationship: knowing one tells you little about the other.

How does this chart handle outliers?

A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 16 companies are outliers on Revenue Growth (1y) (TTM) and 9 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.

Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this sector is included unless you choose primary industry only. Nothing on this page is investment advice.